Get the

Newsletter

Medical use of cannabis. Cannabidiol: a new light for schizophrenia?

Subject: Schizophrenia - PUBLISHED VIA Drug Testing and Analysis

Author(s):
Deiana S

Department CNS Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. K., Biberach an der Riss, Germany. serena.deiana@boehringer-ingelheim.com

View Source >> (Price: $38)

Related Studies:

View all medical studies

Learn More About Cannabis